The Kroger Co (KR) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
11 Sep, 2026Executive summary
Identical sales without fuel grew 0.2% year-over-year, with traffic up but basket size down due to disciplined consumer spending and external headwinds; total sales reached $34.6 billion.
Adjusted eCommerce sales grew 20% and retail media/marketing profit rose 24%, contributing to a second consecutive quarter of profitable e-commerce growth.
Adjusted EPS was $1.09, up 5% year-over-year, and adjusted FIFO operating profit reached $1,076 million.
Pharmacy and fuel segments delivered strong profit and volume growth, with pharmacy benefiting from a branded-to-generic mix shift and fuel gallons sold outpacing the industry by 520 basis points.
The company maintained market share gains versus traditional grocery competitors despite industry-wide softness.
Financial highlights
Adjusted earnings per diluted share was $1.09, a 5% increase from the prior year.
Adjusted FIFO operating profit was $1,076 million, compared to $1,091 million last year.
Gross margin for Q2 was 22.4%, slightly down from 22.5% last year; FIFO gross margin rate (excluding rent, depreciation, amortization, and fuel) increased 13 basis points.
Net income attributable to shareholders was $641 million, with GAAP EPS of $1.05.
Dividend per share for Q2 was $0.39, up from $0.35 in Q2 2025.
Outlook and guidance
Full-year identical sales without fuel guidance lowered to 0.2%-0.8% from 1%-2%, reflecting a 138-140 basis point headwind from the Inflation Reduction Act.
Full-year adjusted FIFO operating profit guidance maintained at $5.0-$5.2 billion; adjusted EPS guidance held at $5.10-$5.30.
Free cash flow expected at $2.7-$2.9 billion; capital expenditures at $3.8-$4.0 billion.
Tax rate guidance is 23%.
Pharmacy headwinds from the Inflation Reduction Act expected to accelerate in Q4 but with no profit impact.
Latest events from The Kroger Co
- Board elections, key proposals, and an 11% dividend increase highlighted; GHG proposal defeated.KR
AGM 2026 - Q1 2026 saw higher sales, 1% identical sales growth, and strong eCommerce profitability.KR
Q1 2027 - Annual meeting covers director elections, pay, auditors, and a GHG report proposal.KR
Proxy filing - Board recommends all management proposals, highlights strong results, and opposes GHG proposal.KR
Proxy filing - Adjusted EPS and operating profit rose, with robust eCommerce and share repurchases in 2025.KR
Q4 2026 - Dividend raised, strong sales, and all shareholder proposals defeated at the annual meeting.KR
AGM 2025 - Digital and pharmacy gains drove Q3 growth; Albertsons merger ended, $7.5B buyback announced.KR
Q3 2025 - Q2 2024 delivered 1.2% sales growth, $0.93 EPS, and strong digital gains amid merger progress.KR
Q2 2025 - Q1 sales and digital growth offset profit declines as guidance and merger focus remain.KR
Q1 2025